Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 42, 2010, Pages 18115-18120

  Liu, Huiping ^a,b   Patel, Manishkumar R ^c   Prescher, Jennifer A ^c   Patsialou, Antonia ^d   Qian, Dalong ^a   Lin, Jiahui ^a   Wen, Susanna ^a   Chang, Ya Fang ^c,e   Bachmann, Michael H ^c   Shimono, Yohei ^a   Dalerba, Piero ^a   Adorno, Maddalena ^a   Lobo, Neethan ^a   Bueno, Janet ^a   Dirbas, Frederick M ^c   Goswami, Sumanta ^d,f   Somlo, George ^g   Condeelis, John ^d   Contag, Christopher H ^c   Gambhir, Sanjiv Sam ^c,h   Clarke, Michael F ^a   more..

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c STANFORD UNIVERSITY   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f YESHIVA UNIVERSITY   (United States)

^g CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^h Stanford University   (United States)

Author keywords

Bioluminescence imaging; Breast cancer; Fused optical reporters; Human in mouse cancer models

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER STEM CELL; CARCINOGENESIS; HUMAN; IN VIVO STUDY; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS;

EID: 78149262994     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1006732107     Document Type: Article

References (48)

1. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730-737. (Pubitemid 27298715)
2. Lapidot T, et al. (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645-648.
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983-3988. (Pubitemid 36418143)
4. Bao S, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756-760. (Pubitemid 44949604)
5. Cho RW, et al. (2008) Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells 26:364-371.
6. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65:10946-10951.
7. Dalerba P, et al. (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104:10158-10163.
8. Fang D, et al. (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65:9328-9337.
9. Hermann PC, et al. (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313-323.
10. Li C, et al. (2007) Identification of pancreatic cancer stem cells. Cancer Res 67:1030-1037.
11. Ma S, et al. (2007) Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132:2542-2556. (Pubitemid 46890873)
12. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110. (Pubitemid 46067310)
13. Prince ME, et al. (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104:973-978.
14. Ricci-Vitiani L, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115. (Pubitemid 46067311)
15. Singh SK, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828.
16. Chan KS, et al. (2009) Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci USA 106:14016-14021.
17. Lawson JC, Blatch GL, Edkins AL (2009) Cancer stem cells in breast cancer and metastasis. Breast Cancer Res Treat 118:241-254.
18. Diehn M, et al. (2009) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458:780-783.
19. Oravecz-Wilson KI, et al. (2009) Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder. Cancer Cell 16:137-148.
20. Liu R, et al. (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356:217-226.
21. Mani SA, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715.
22. Shimono Y, et al. (2009) Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138:592-603.
23. Chiang AC, Massagué J (2008) Molecular basis of metastasis. N Engl J Med 359:2814-2823.
24. Nguyen DX, Bos PD, Massagué J (2009) Metastasis: From dissemination to organ-specific colonization. Nat Rev Cancer 9:274-284.
25. Padua D, Massagué J (2009) Roles of TGFbeta in metastasis. Cell Res 19:89-102.
26. Wyckoff JB, Segall JE, Condeelis JS (2000) The collection of the motile population of cells from a living tumor. Cancer Res 60:5401-5404.
27. Creusot RJ, et al. (2008) Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice. Clin Immunol 127:176-187.
28. Edinger M, et al. (2003) Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 101:640-648. (Pubitemid 36077588)
29. Mandl SJ, et al. (2004) Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome. Mol Imaging 3:1-8.
30. Ray P, De A, Min JJ, Tsien RY, Gambhir SS (2004) Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 64:1323-1330. (Pubitemid 38235600)
31. Ray P, Tsien R, Gambhir SS (2007) Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. Cancer Res 67:3085-3093. (Pubitemid 46724845)
32. Yaghoubi SS, Creusot RJ, Ray P, Fathman CG, Gambhir SS (2007) Multimodality imaging of T-cell hybridoma trafficking in collagen-induced arthritic mice: Image-based estimation of the number of cells accumulating in mouse paws. J Biomed Opt 12:064025.
33. Prescher JA, Contag CH (2010) Guided by the light: Visualizing biomolecular processes in living animals with bioluminescence. Curr Opin Chem Biol 14:80-89.
34. Paguio A, et al. (2005) pGL4 vectors: A new generation of luciferase reporter vectors. Promega Notes 89:4.
35. Shaner NC, et al. (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 22:1567-1572.
36. Wang W, et al. (2007) Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors. Cancer Res 67:3505-3511. (Pubitemid 46762128)
37. Perou CM, et al. (2000) Molecular portraits of human breast tumours. Nature 406:747-752.
38. Rakha EA, Reis-Filho JS, Ellis IO (2008) Basal-like breast cancer: a critical review. J Clin Oncol 26:2568-2581.
39. Sørlie T, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874.
40. Sorlie T, et al. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418-8423.
41. Zhao H, et al. (2004) Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 15:2523-2536.
42. Bosch A, Eroles P, Zaragoza R, Viña JR, Lluch A (2010) Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research. Cancer Treat Rev 36:206-215.
43. Contag CH, Jenkins D, Contag PR, Negrin RS (2000) Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2:41-52. (Pubitemid 30123179)
44. Dent R, et al. (2009) Pattern of metastatic spread in triple-negative breast cancer. Breast Cancer Res Treat 115:423-428.
45. Abraham BK, et al. (2005) Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res 11:1154-1159.
46. Ginestier C, et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555-567.
47. Giatromanolaki A, Sivridis E, Fiska A, Koukourakis MI (2010) The CD44+/CD24-phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients. Med Oncol, 10.1007/s12032-010-9530-3.
48. McAllister SS, et al. (2008) Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 133:994-1005.